Condensed Consolidated Statements of Operations and Comprehensive Loss (Unaudited) - USD ($)	3 Months Ended
	Mar. 31, 2023	Mar. 31, 2022
Operating expenses
General and administrative	$ 2,784,191	$ 2,767,866
Research and development	1,990,001	1,958,714
Depreciation and amortization	86,486	69,265
Total operating expenses	4,860,678	4,795,845
Loss from operations	(4,860,678)	(4,795,845)
Other income (expense)
Change in fair value of warrant liabilities	50,657	275,969
Change in fair value of investment option liability	119,505
Change in fair value of derivative liability	13,000
Interest expense	(11)	(4,138)
Total other income	183,151	271,831
Net loss	(4,677,527)	(4,524,014)
Less preferred dividends attributable to non-controlling interest	12,329
Less deemed dividends attributable to accretion of embedded derivative at redemption value	110,991
Net loss attributable to shareholders	(4,800,847)	(4,524,014)
Other comprehensive loss
Foreign currency translation	1,968	88,709
Comprehensive loss	$ (4,798,879)	$ (4,435,305)
Net loss per share - basic and diluted	$ (2.31)	$ (5.34)
Weighted average shares outstanding, basic and diluted	2,078,271	847,136